Login / Signup

Aiming at the Right Targets on Drug Price Reform.

Stacie B Dusetzina
Published in: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics (2024)
A lack of transparency and concerns over patients costs at the pharmacy counter have increased Congressional focus on pharmacy benefits management practices. However, applying regulations without transparency into pharmacy benefits managers practices could do more harm than good.
Keyphrases
  • primary care
  • end stage renal disease
  • healthcare
  • chronic kidney disease
  • newly diagnosed
  • ejection fraction
  • emergency department
  • health insurance
  • patient reported outcomes
  • drug induced
  • affordable care act